首頁 > 市場調查報告書 > 醫療設備

病患監測

市場調查報告書

商品編碼

1495991

胎兒和新生兒護理設備市場：2024-2029年預測

Fetal & Neonatal Care Equipment Market - Forecasts from 2024 to 2029

出版日期: 2024年04月17日 | 出版商:

Knowledge Sourcing Intelligence | 英文 139 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄

全球胎兒和新生兒護理設備市場的複合年成長率為6.48%，從2022年的98.09億美元增加到2029年底的152.27億美元。

胎兒和新生兒護理設備為診斷患有疾病的新生兒和胎兒提供護理，無論是出於監測、治療還是診斷目的。這些設備包括照光治療設備、培養箱、心肺監視器、臍導管、脈動式血氧監測儀系統等。

由於全球早產率不斷上升，預計該市場將快速成長。先天性疾病的增加進一步增加了預測期內的市場需求。技術進步帶來的先進系統的可用性是未來五年進一步推動市場成長的驅動力。

此外，不孕症旅遊的擴張需要最先進的設備來監測胎兒和新生兒的健康狀況，這進一步為預測期內的市場擴張提供了機會。對 35 歲及以上母親懷孕和分娩期間併發症風險增加的擔憂也將在預測期內擴大市場。

市場促進因素：

生育旅遊熱度持續擴大市場

生育旅遊，也稱為跨境生殖保健（CBRC），在全球範圍內越來越受歡迎，因為不孕夫婦和人們（包括單身人士、同性戀者和跨性別者）在本國以外尋求有效的生育治療。採用海外生殖醫學的主要原因包括本國的法律法規和高昂的治療費用。

除其他原因外，治療質量，即成功率、漫長的等待時間和社會文化因素在選擇國外不孕症治療時起著重要作用。最常見的不孕症治療包括體外受精、顯微授精、捐贈精子、捐贈卵子和保留生育能力。

世界各地男性和女性不孕症發病率的增加是推動生育旅遊的主要因素之一。在美國，大約 10% 15 歲至 44 歲之間的女性難以懷孕或維持懷孕。在國際上，估計超過8%的夫婦有不孕問題。此外，根據分析，近50%的不孕症患者受男性影響。因此，隨著生殖醫學需求的增加，市場預計將顯著成長。

男性不孕症是由某些疾病引起的，例如糖尿病、甲狀腺疾病、遺傳性疾病和荷爾蒙失衡。女性不孕不育的原因是不健康的生活方式，如吸煙、主動或被動、肥胖或超重、接觸化學物質以及精神壓力。

剖腹產手術的數量正在增加，為預測期內的市場成長提供了機會。

人們普遍注意到剖腹產率正在迅速增加。此外，據觀察，在中國、東南歐和拉丁美洲國家等地區，剖腹產率超過了陰道分娩的數量。即使在低度開發國家，剖腹產率也相當高。例如，眾所周知，在孟加拉國，不到 60% 的分娩是在診所進行的，其中約 65% 是剖腹產。因此，剖腹產的增加為市場帶來了巨大的成長機會。

全球和地區剖腹產率的增加是由於在醫療保健機構中分娩的比例不斷增加，這是有原因的。此外，有人指出，在低收入和中等收入國家，剖腹產在最富有的人中比貧困階級的人中更為普及。

此外，在低產科風險分娩中，剖腹產的使用率較高，尤其是在受過教育的女性中。例如，在巴西和中國，私人醫療機構進行剖腹產的可能性大約是公共醫療機構的 1.6 倍。作為剖腹產計劃的一部分，剖腹產需要在分娩後持續監測胎兒和新生兒，這將進一步增加預測期內的市場需求。

作為剖腹產計劃的一部分，剖腹產的採用需要對分娩後的胎兒和新生兒進行持續監測，從而增加了預測期內的市場需求。世界衛生組織建議的剖腹產率為10-15%。對於低風險女性，建議從目前約27-24%的年率降低。在美國，這一比例要高得多，約為 32%。

北美地區作為市場佔有重要地位。

從地區來看，由於北美為母親及其新生兒提供先進的醫療保健設施，預計在預測期內將佔據很大的市場佔有率。美國的醫療保健成本最高，進一步推動了預測期內市場的成長。從基於數量的醫療保健向基於價值的醫療保健的轉變進一步增強了預測期內市場成長的前景。

主要進展

2024 年 1 月：Butterfly Network 的新一代手持式超音波系統 Butterfly iQ3 獲得 FDA 批准。該設備是世界上第一個基於半導體的單探頭全身超音波系統的第三次迭代。 Butterfly iQ3將資料處理速度提高了一倍，以最佳化影像解析度、靈敏度和滲透性，並在自動影像捕捉模式下加速了3D功能。
2023 年 11 月 - 皇家飛利浦獲得比爾及梅琳達蓋茲基金會的第二輪資金，以加速 Lumify 手持式超音波人工智慧演算法的全球普及。該技術簡化了妊娠異常的識別，並將訓練時間從幾週縮短到幾小時。這筆資金將支持將人工智慧輔助工具部署到世界服務不足的地區。 Lumify 手持式超音波是首款商業性推出的照護現場超音波設備，可自動擷取並解釋產科測量的影像。

介紹
北美洲
- 按類型
- 依產品
- 按最終用戶
- 按國家/地區
南美洲
- 按類型
- 依產品
- 按最終用戶
- 按國家/地區
歐洲
- 按類型
- 依產品
- 按最終用戶
- 按國家/地區
中東/非洲
- 按類型
- 依產品
- 按最終用戶
- 按國家/地區
亞太地區
- 按類型
- 依產品
- 按最終用戶
- 按國家/地區

第9章競爭環境及分析

主要企業及策略分析
市場佔有率分析
合併、收購、協議和合作
競爭對手儀表板

第10章公司簡介

Aspect Imaging Ltd.
General Electric Company
EMCO Meditek Pvt. Ltd.
Fisher & Paykel Healthcare Limited
Masimo Corporation
Natus Medical Incorporated
Phoenix Medical Systems（P）Ltd.
Dragerwerk AG & Co. KGaA
Spacelabs Healthcare（OSI Systems, Inc.）
Becton, Dickinson and Company

簡介目錄

Product Code: KSI061611882

The global fetal & neonatal care equipment market is evaluated to surge at a CAGR of 6.48% from a market value of USD9.809 billion in 2022 to reach USD15.227 billion by the end of 2029.

Fetal & neonatal care equipment, whether for monitoring, treatment, or diagnostic purposes, offers care to a newborn or an unborn fetus diagnosed with a medical condition. These pieces of equipment comprise phototherapy equipment, incubators, cardiopulmonary monitors, umbilical catheters, pulse oximeters, and many more.

The market is projected to grow at a fast pace with the growing preterm birth rates at the global level. The growing incidences of congenital diseases are further augmenting the market demand during the forecast period. The availability of advanced systems due to technological advancements is further providing an impetus to fuel the market growth over the next five years.

Additionally, growing fertility tourism demands state-of-the-art equipment for monitoring fetal and newborn health, further providing an opportunity for the market to propagate during the forecast period. Concerns about the increased risk of complications during pregnancy and delivery for mothers over the age of 35 also expand the market during the forecast period.

Market Drivers:

The growing popularity of fertility tourism will continue to proliferate the market

Fertility tourism, also known as cross-border reproductive care (CBRC), is gaining popularity at the global level, where people, including infertile couples and single, gay, or transgender individuals, are seeking effective fertility treatments outside of their home countries. The major reasons for the adoption of reproductive treatments abroad include legal restrictions and the high cost of treatment in their home countries.

Among other reasons, quality of care, i.e., success rate, long waits, and sociocultural considerations, play a significant role in choosing fertility treatments abroad. The most common forms of fertility treatments involve in vitro fertilization, intracytoplasmic sperm injection, sperm donation, egg donation, and fertility preservation, among others.

Growing infertility among males and females worldwide is one of the major factors driving fertility tourism. In the United States, it has been observed that around 10% of women aged between 15 and 44 years of age are experiencing difficulty in conceiving or staying pregnant. On an international level, it has been estimated that over 8% of couples are affected by fertility issues. It has been further analyzed that out of all the infertility cases, close to 50% of them are affecting males. Hence, with this, the market is projected to show strong prospects for growth along with a greater demand for reproductive care.

Infertility in males is due to specific medical conditions like diabetes, thyroid disorders, genetic disorders, and hormonal imbalances, among others. For females, infertility arises due to the adoption of unhealthy living conditions like smoking, being active or passive, being obese or overweight, exposure to chemicals, and mental stress, among others.

The rising number of cesarean sections provides an opportunity for the market to thrive during the forecast period.

It has been widely noted that the rate of C-sections is growing at a rapid pace. Furthermore, it has been observed that the rate of cesarean has exceeded the number of vaginal deliveries in the regions of China, Southeast Europe, and Latin American countries. Even in less-developed nations, the rate of C-sections is quite high. For instance, in Bangladesh, less than 60% of births are known to occur in clinics, and of those, around 65% are C-sections. Hence, the market is provided with considerable growth opportunities with rising cesarean deliveries.

The global and regional increase in the adoption of cesarean section is attributed to the growing proportion of births taking place in healthcare facilities, along with the increase in cesarean use in these health facilities. It was further noticed that cesarean section usage was more prevalent in the richest countries than the poorest in low-income and middle-income countries.

Furthermore, high C-section use was observed among individuals with low obstetric-risk births, particularly among educated females. For instance, in Brazil and China, C-sections were estimated to be around 1.6 times more frequently performed in a private healthcare setting than in a public healthcare setting. The adoption of C-sections will require constant monitoring of the fetus and the newborn after delivery as a part of the C-section planning, further augmenting the market demand in the forecast period.

The adoption of C-sections will necessitate continuous monitoring of the fetus and newborn after delivery as part of the C-section planning, which will increase market demand during the forecast period. The WHO proposed rate for C-sections is 10-15%. It has been recommended that the annual rate should decline in low-risk females from the current rate of around 27-24%. In the United States, the rate is much higher, at around 32%.

The North American region is accounted to hold a significant marketplace.

Geographically, North America is projected to hold a significant market share in the forecast period owing to the advanced healthcare facilities for mothers and their newborns. The highest health expenditure in the United States is further contributing to surging market growth in the forecast period. The shift from volume-based care to value-based care is further offering strong market growth prospects in the forecast period.

Key developments:

January 2024- Butterfly Network received FDA clearance for its next-generation handheld ultrasound system, Butterfly iQ3. This device is the third iteration of the world's first semiconductor-based single-probe, whole-body ultrasound system. Butterfly iQ3 offers double the data processing speed for optimized image resolution, sensitivity, and penetration, as well as faster 3D capabilities for automated image capture modes. The device is designed to make ultrasound more accessible and approachable than ever before, making it a turning point in digital ultrasound technology.
November 2023- Royal Philips secured a second round of funding from the Bill & Melinda Gates Foundation to accelerate the global adoption of AI algorithms on its Lumify Handheld Ultrasound. The technology simplifies pregnancy abnormality identification, reducing training time from weeks to just hours. The funding supports the deployment of the AI-assisted tool to underserved communities globally. The Lumify Handheld Ultrasound is the first point-of-care ultrasound device to be introduced commercially, automating image acquisition and interpretation for obstetrics measurements.

Market Segmentation:

By Type

Fetal Care
Neonatal Care

By Product

Monitors
Treatment Equipment
Diagnostic Equipment

By End-User

Hospitals
Clinics
Research Centers

By Geography

North America
USA
Canada
Mexico
South America
Brazil
Argentina
Others
Europe
UK
Germany
France
Italy
Others
Middle East and Africa
UAE
Israel
Saudi Arabia
Others
Asia Pacific
Japan
China
India
South Korea
Thailand
Taiwan
Indonesia
Others

1. INTRODUCTION

1.1. Market Overview
1.2. Market Definition
1.3. Scope of the Study
1.4. Market Segmentation
1.5. Currency
1.6. Assumptions
1.7. Base and Forecast Years Timeline
1.8. Key Benefits to the Stakeholder

2. RESEARCH METHODOLOGY

2.1. Research Design
2.2. Research Processes

3. EXECUTIVE SUMMARY

3.1. Key Findings

4. MARKET DYNAMICS

4.1. Market Drivers
4.2. Market Restraints
4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers
- 4.3.2. Bargaining Power of Buyers
- 4.3.3. Threat of New Entrants
- 4.3.4. Threat of Substitutes
- 4.3.5. Competitive Rivalry in the Industry
4.4. Industry Value Chain Analysis
4.5. Analyst View

5. FETAL & NEONATAL CARE EQUIPMENT MARKET BY TYPE

5.1. Introduction
5.2. Fetal Care
- 5.2.1. Market Opportunities and Trends
- 5.2.2. Growth Prospects
- 5.2.3. Geographic Lucrativeness
5.3. Neonatal Care
- 5.3.1. Market Opportunities and Trends
- 5.3.2. Growth Prospects
- 5.3.3. Geographic Lucrativeness

6. FETAL & NEONATAL CARE EQUIPMENT MARKET BY PRODUCT

6.1. Introduction
6.2. Monitors
- 6.2.1. Market Opportunities and Trends
- 6.2.2. Growth Prospects
- 6.2.3. Geographic Lucrativeness
6.3. Treatment Equipment
- 6.3.1. Market Opportunities and Trends
- 6.3.2. Growth Prospects
- 6.3.3. Geographic Lucrativeness
6.4. Diagnostic Equipment
- 6.4.1. Market Opportunities and Trends
- 6.4.2. Growth Prospects
- 6.4.3. Geographic Lucrativeness

7. FETAL & NEONATAL CARE EQUIPMENT MARKET BY END-USER

7.1. Introduction
7.2. Hospitals
- 7.2.1. Market Opportunities and Trends
- 7.2.2. Growth Prospects
- 7.2.3. Geographic Lucrativeness
7.3. Clinics
- 7.3.1. Market Opportunities and Trends
- 7.3.2. Growth Prospects
- 7.3.3. Geographic Lucrativeness
7.4. Research Centers
- 7.4.1. Market Opportunities and Trends
- 7.4.2. Growth Prospects
- 7.4.3. Geographic Lucrativeness

8. FETAL & NEONATAL CARE EQUIPMENT MARKET BY GEOGRAPHY

8.1. Introduction
8.2. North America
- 8.2.1. By Type
- 8.2.2. By Product
- 8.2.3. By End-User
- 8.2.4. By Country
  - 8.2.4.1. USA
    - 8.2.4.1.1. Market Opportunities and Trends
    - 8.2.4.1.2. Growth Prospects
  - 8.2.4.2. Canada
    - 8.2.4.2.1. Market Opportunities and Trends
    - 8.2.4.2.2. Growth Prospects
  - 8.2.4.3. Mexico
    - 8.2.4.3.1. Market Opportunities and Trends
    - 8.2.4.3.2. Growth Prospects
8.3. South America
- 8.3.1. By Type
- 8.3.2. By Product
- 8.3.3. By End-User
- 8.3.4. By Country
  - 8.3.4.1. Brazil
    - 8.3.4.1.1. Market Opportunities and Trends
    - 8.3.4.1.2. Growth Prospects
  - 8.3.4.2. Argentina
    - 8.3.4.2.1. Market Opportunities and Trends
    - 8.3.4.2.2. Growth Prospects
  - 8.3.4.3. Others
    - 8.3.4.3.1. Market Opportunities and Trends
    - 8.3.4.3.2. Growth Prospects
8.4. Europe
- 8.4.1. By Type
- 8.4.2. By Product
- 8.4.3. By End-User
- 8.4.4. By Country
  - 8.4.4.1. UK
    - 8.4.4.1.1. Market Opportunities and Trends
    - 8.4.4.1.2. Growth Prospects
  - 8.4.4.2. Germany
    - 8.4.4.2.1. Market Opportunities and Trends
    - 8.4.4.2.2. Growth Prospects
  - 8.4.4.3. France
    - 8.4.4.3.1. Market Opportunities and Trends
    - 8.4.4.3.2. Growth Prospects
  - 8.4.4.4. Italy
    - 8.4.4.4.1. Market Opportunities and Trends
    - 8.4.4.4.2. Growth Prospects
  - 8.4.4.5. Others
    - 8.4.4.5.1. Market Opportunities and Trends
    - 8.4.4.5.2. Growth Prospects
8.5. Middle East and Africa
- 8.5.1. By Type
- 8.5.2. By Product
- 8.5.3. By End-User
- 8.5.4. By Country
  - 8.5.4.1. UAE
    - 8.5.4.1.1. Market Opportunities and Trends
    - 8.5.4.1.2. Growth Prospects
  - 8.5.4.2. Israel
    - 8.5.4.2.1. Market Opportunities and Trends
    - 8.5.4.2.2. Growth Prospects
  - 8.5.4.3. Saudi Arabia
    - 8.5.4.3.1. Market Opportunities and Trends
    - 8.5.4.3.2. Growth Prospects
  - 8.5.4.4. Others
    - 8.5.4.4.1. Market Opportunities and Trends
    - 8.5.4.4.2. Growth Prospects
8.6. Asia Pacific
- 8.6.1. By Type
- 8.6.2. By Product
- 8.6.3. By End-User
- 8.6.4. By Country
  - 8.6.4.1. Japan
    - 8.6.4.1.1. Market Opportunities and Trends
    - 8.6.4.1.2. Growth Prospects
  - 8.6.4.2. China
    - 8.6.4.2.1. Market Opportunities and Trends
    - 8.6.4.2.2. Growth Prospects
  - 8.6.4.3. India
    - 8.6.4.3.1. Market Opportunities and Trends
    - 8.6.4.3.2. Growth Prospects
  - 8.6.4.4. South Korea
    - 8.6.4.4.1. Market Opportunities and Trends
    - 8.6.4.4.2. Growth Prospects
  - 8.6.4.5. Thailand
    - 8.6.4.5.1. Market Opportunities and Trends
    - 8.6.4.5.2. Growth Prospects
  - 8.6.4.6. Taiwan
    - 8.6.4.6.1. Market Opportunities and Trends
    - 8.6.4.6.2. Growth Prospects
  - 8.6.4.7. Indonesia
    - 8.6.4.7.1. Market Opportunities and Trends
    - 8.6.4.7.2. Growth Prospects
  - 8.6.4.8. Others
    - 8.6.4.8.1. Market Opportunities and Trends
    - 8.6.4.8.2. Growth Prospects